A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT07035093
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Chronic Low Back Pain (CLBP)
- Obesity
- Overweight
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Retatrutide — DRUGAdministered SC
- Placebo — DRUGAdministered SC
Study Details
The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
Key Dates
- Start date
- May 29, 2025
- Status verified
- May 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 586 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RetatrutideParticipants will receive Retatrutide subcutaneously (SC)
- Placebo Comparator: PlaceboParticipants will receive Placebo SC
Primary Outcome Measure
Change from Baseline in Pain Intensity Per Numeric Rating Scale [ Time Frame: Baseline, up to 72 weeks ]
Central Contacts
- Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or1-317-615-4559
- Physicians interested in becoming principal investigators please contact
Locations (25)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD First Research - Chandler | Chandler | Arizona | 85286 | 480-508-1038 Hemant Pandey (PRINCIPAL_INVESTIGATOR) |
| Tucson Orthopaedic Institute - North Wyatt Drive | Tucson | Arizona | 85712 | 520-404-0276 Nebojsa Skrepnik (PRINCIPAL_INVESTIGATOR) |
| Ark Clinical Research - Fountain Valley | Fountain Valley | California | 92708 | 714-988-2021 Justin Yanuck (PRINCIPAL_INVESTIGATOR) |
| St Joseph Heritage Healthcare | Fullerton | California | 92835 | 714-626-8610 Shirley Pang (PRINCIPAL_INVESTIGATOR) |
| Clinical Research Institute | Los Angeles | California | 90048 | 323-879-9999 David Kudrow (PRINCIPAL_INVESTIGATOR) |
| Artemis Institute for Clinical Research | San Diego | California | 92123 | 858-278-3647 Stacey Layle (PRINCIPAL_INVESTIGATOR) |
| Alpine Clinical Research Center | Boulder | Colorado | 80301 | 303-443-7229 Paul Brownstone, MD (PRINCIPAL_INVESTIGATOR) |
| K2 Medical Research - Daytona Beach | Daytona Beach | Florida | 32114 | Joshua Eisenhut (PRINCIPAL_INVESTIGATOR) |
| Flourish Research - Miami, LLC | Miami | Florida | 33135 | 305-631-6704 Mark Kutner (PRINCIPAL_INVESTIGATOR) |
| IMA Clinical Research St. Petersburg | St. Petersburg | Florida | 33704 | 727-521-9137 Howard Chipman (PRINCIPAL_INVESTIGATOR) |
| Care Access - Tampa | Tampa | Florida | 33625 | 813-771-5980 Shital Mehta (PRINCIPAL_INVESTIGATOR) |
| Charter Research - Lady Lake | The Villages | Florida | 32162 | Stephen Miller (PRINCIPAL_INVESTIGATOR) |
| Conquest Research | Winter Park | Florida | 32789 | 407-916-0060 Anand Patel (PRINCIPAL_INVESTIGATOR) |
| Cotton O'Neil Clinical Research Center | Topeka | Kansas | 66606 | 785-354-9591 Katherine Willingham (PRINCIPAL_INVESTIGATOR) |
| Care Access - Lake Charles (Bayou Pines) | Lake Charles | Louisiana | 70601 | 337-602-6642 William Nabours (PRINCIPAL_INVESTIGATOR) |
| MedVadis Research Corporation | Waltham | Massachusetts | 02451 | 617-744-1310 David DiBenedetto (PRINCIPAL_INVESTIGATOR) |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | 989-895-9100 Jeffrey Potts (PRINCIPAL_INVESTIGATOR) |
| Clinvest Headlands Llc | Springfield | Missouri | 65807 | 417-883-7889 Ralph Duda (PRINCIPAL_INVESTIGATOR) |
| Center for Clinical Research | Winston-Salem | North Carolina | 27103 | Leonardo Kapural (PRINCIPAL_INVESTIGATOR) |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | 814-693-0300 Alan Kivitz (PRINCIPAL_INVESTIGATOR) |
| New Phase Research and Development | Knoxville | Tennessee | 37909 | Natalie Clarke (PRINCIPAL_INVESTIGATOR) |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | 512-380-9925 Gregory Tempest (PRINCIPAL_INVESTIGATOR) |
| Mercy Family Clinic | Dallas | Texas | 75208 | 281-944-3610 Ebere Israel Azubuike, MD (PRINCIPAL_INVESTIGATOR) |
| Houston Research Institute | Houston | Texas | 77079 | 281-809-3234 David Huang (PRINCIPAL_INVESTIGATOR) |
| Sovah Clinical Research-River District | Danville | Virginia | 24541 | James Dailey (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chandler, AZ
By condition
By specialty
By research site
MD First Research - Chandler· Chandler, AZTucson Orthopaedic Institute - North Wyatt Drive· Tucson, AZArk Clinical Research - Fountain Valley· Fountain Valley, CASt Joseph Heritage Healthcare· Fullerton, CAClinical Research Institute· Los Angeles, CAArtemis Institute for Clinical Research· San Diego, CA
Related Studies
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.Recruiting · Columbia University · Boston, Massachusetts
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight MaintenanceRecruiting · University of Michigan · Ann Arbor, Michigan
- Healthy Start: Exploring the Fuel-mediated Programming of Neonatal GrowthRecruiting · University of Colorado, Denver · Aurora, Colorado